Next-Gen Solutions The Role of Artificial Intelligence in Pharma Manufacturing
Related Vendors
Today Artificial Intelligence has entered every industry and the pharma sector is no different. Major pharma companies are actively making use of AI to accelerate drug discovery and carry out efficient clinical trials. However, integrating this technology into GxP-compliant pharma production still remains a complex challenge.
The global Artificial Intelligence (AI) in Pharmaceutical Market was valued at 1.73 billion dollars in 2024 and is anticipated to reach 13.46 billion dollars by 2032, expanding at a CAGR of 29.33 % during the forecast period 2025-2032, according to a press release by market research company SNS Insider. It further states that the global artificial intelligence pharmaceutical market is growing rapidly with increasing demand for rapid drug discovery, precision medicine, and efficient clinical trials. This holds true as some of the biggest names in the pharma industry are actively using AI for all the applications mentioned earlier.
AI in action
Sign in or register and read on
Please log in or register and read this article. To be able to read this article in full, you must be registered. Free registration gives you access to exclusive specialist information.
Already registered? Log in here